BRISTOL LABORATORIES GROUP LIMITEDActive
Key figures
BRISTOL LABORATORIES GROUP LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024/25Balance sheet structure
Filed accounts2020/21–2024/25
| 2020/21 | 2021/22 | 2023/24 | 2024/25 | |
|---|---|---|---|---|
| Profit for the year | 0 | 13,175,379 | 0 | -19,715,294 |
| Total assets | — | — | — | — |
| Total liabilities | — | — | — | 0 |
| Net assets / total equity | 19,715,295 | — | 19,715,295 | 1 |
| Average number of employees | 1 | 682 | 1 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the group continued to be that of pharmaceutical group engaged in the development, manufacture, marketing and distribution of generic medicines.
As described in the company's latest filed accounts.
Summary: BRISTOL LABORATORIES GROUP LIMITED
Company
BRISTOL LABORATORIES GROUP LIMITED is a private limited company registered with Companies House under company number 08954173. It was incorporated on 24 Mar 2014. Its status is active. The registered office is in London (W1U). Its nature of business (SIC 2007) is activities of head offices (70100).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files group accounts. Loss for the year was £19,715,294. Net assets were £1, down 100% on the previous year. The company had an average of 0 employees. Figures are available for 4 financial years (2020/21–2024/25).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 7 Apr 2027.